SOMOS Familia Biobank
As Latinos-Hispanics we represent less than 1% of ancestry populations included in genomic studies

Despite being 25% of world's pharmaceutical revenue and accounting for 1/6 (+60M) of the US population (largest minority) and +650M worlwide, there has never been a drug specifically developed for Latinos.
We barely exist for science considering that we represent less than 1% of clinical trials!

Our People, Our Mission | Your DNA, Your data
We are the revolutionized 23andMe for Latinos creating state of the art algorithms and unique datasets derived from years of R&D;
We have developed the highest resolution ancestry service for Latinos by
creating the most complete genome reference panel for Latinos.
SOMOS algorithms and platform allow users to connect back with their indigenous roots in just a couple clicks and a saliva sample.
We are representing +800 Indigenous Nations in the worlds first:
Decentralized Panamerican Biobank (The SOMOS Familia Biobank)
SOMOS is the first ancestry company to succesfully implement through strategic partnerships (genobank.io) a blockchain based DNA wallet that enables full governance and ownership to each user over their DNA data (as it always should be!)
There are +650Million Latinos worlwide (almost 10% of worlds population)
+60Million Latinos in the US will have the best platform with expanded services beyond just high resolution ancestry.
Considering MIT has predicted 100M ancestry users by the end of 2022 and the growth of the Latino population in the US, we can expect close to +18M Latinos taking a DNA test within the next years.
It is well known for science that populations react different to drugs and medical treatments.By including one of the most genetically diverse populations (Latinos), researchers and companies will have access to unique data that can help identify new potential targets for drug discovery and tailored treatments that will benefit our latino communities
In order to expand the quality and resolution of our services we are
creating the worlds first decentralized panamerican biobank, without
owning any samples.
Instead SOMOS walks the talk, we establish long term, sustainable and transparent relationships with Indigenous communities to generate decentralized data that derives in unique knowledge.
Our first mission is to serve our indigenous Nations in Mexico+70 communities and +500 in Latin America (phase 2-3)
We continue to scale our resolution and services to become by 2023 the first platform to enable Precision Medicine for Latinos.
We met 13 year ago in Med School, have worked together in Mi ADN (first company incorporated in Mexico by Federico). Have turned a long and lasting friendship into a shared passion. We received two grants by the Mexican Government to do genetic research in indigenous communities;
2019 winners of Masschallenge-Accelhub Bridge to Boston,2020 winners of LatinX Fest,2021 Voces de la comunidad Latina in the US.
We are passionate for technology in Medicine as a powerful tool to help exponentially.
We have built a group of professionals, researchers, advisors,ambassadors and teammates with unique experience in health, understanding of the Latino communities from the social, scientific and commercial perspectives.
- Build fundamental, resilient, and people-centered health infrastructure that makes essential services, equipment, and medicines more accessible and affordable for communities that are currently underserved;
- Growth
SOMOS is a community dependant, mission driven solution that generates social impact within a community level. Being of part of MIT Solve will help us create strategic alliances and identify potential partners to scale faster prioritizing return on society before return on investment.
We are a voice for the underepresented communities and partnerships are the best way to create sustainable impact
- Business model (e.g. product-market fit, strategy & development)

CEO
MD & CTO